About Michael Kulper
Form D filings for Nivagen Pharmaceuticals in 2023 list Michael Kulper as director.
Michael Kulper first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Michael Kulper in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Michael Kulper works with at each company, as listed on that company's latest Form D.
Nivagen Pharmaceuticals, Inc. · Form D, Aug 11, 2023
DL
Dasaradhi Lakkaraju
Executive officer
JM
Jaswinder Matharu
Director
GP
Gopal Patel
Executive officer
JS
Jwalant Shukla
CEO and director
RH
Rob Hart
Director
AS
Ashish Sevak
Director
PD
Praneel Deo
Executive officer